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DNGR-1 is a C-type lectin receptor that binds F-actin
exposed by dying cells and facilitates cross-presen-
tation of dead cell-associated antigens by dendritic
cells. Herewepresent the structure ofDNGR-1bound
to F-actin at 7.7 A˚ resolution. Unusually for F-actin
binding proteins, the DNGR-1 ligand binding domain
contacts three actin subunits helically arranged in the
actin filament, bridging over two protofilaments, as
well as two neighboring actin subunits along one pro-
tofilament.Mutation of residues predicted tomediate
ligand binding led to loss of DNGR-1-dependent
cross-presentation of dead cell-associated antigens,
formally demonstrating that the latter depends on
F-actin recognition. Notably, DNGR-1 has relatively
modest affinity for F-actinbutmultivalent interactions
allow amarked increase in binding strength. Our find-
ings shed light on modes of actin binding by cellular
proteins and reveal how extracellular detection of
cytoskeletal components by dedicated receptors
allows immunemonitoring of loss of cellular integrity.
INTRODUCTION
Damage to tissues releases damage-associated molecular pat-
terns (DAMPs), which elicit an inflammatory response designed
to maintain sterility and promote repair of the injured site. In ver-
tebrates, DAMPs can additionally promote adaptive immune re-
sponses to foreign antigens contained within damaged cells in
what might be the major pathway for initiating immunity against
tumors and some viruses (Zelenay and Reis e Sousa, 2013).
DNGR-1 (also known as CLEC9A) is an innate immune receptor
specific for a DAMP exposed by dead cells (Sancho et al., 2009).
DNGR-1 is specifically expressed by dendritic cells (DCs), aleukocyte subset responsible for initiation and regulation of im-
mune responses (Caminschi et al., 2008; Huysamen et al.,
2008; Poulin et al., 2012; Poulin et al., 2010; Sancho et al.,
2008). DNGR-1 signaling in response to dead cell recognition fa-
cilitates cross-presentation of dead-cell-associated antigens by
DCs and priming of cytotoxic T lymphocytes against cytopathic
viruses (Iborra et al., 2012; Sancho et al., 2009; Zelenay et al.,
2012). Recently, we and others reported that the DAMP recog-
nized by DNGR-1 is the filamentous form of actin (Ahrens
et al., 2012; Zhang et al., 2012), a ubiquitous and abundant intra-
cellular component of eukaryotic cells. F-actin recognition ex-
plains how DNGR-1 can act as a universal detector of dead cells
and reveals cytoskeletal exposure as a means of innate immune
detection of cell damage.
DNGR-1 is a disulphide-bonded homo-dimeric type II trans-
membrane protein of the C-type lectin superfamily (Huysamen
et al., 2008; Sancho et al., 2008). The extracellular domain
(ECD) of each DNGR-1 monomer contains a single C-type lec-
tin-like domain (CTLD) bearing the ligand-binding site, followed
by a membrane-proximal ‘‘neck’’ region of isoform-specific
length consisting of 48 to 74 amino acids (Huysamen et al.,
2008; Sancho et al., 2008). The crystal structure of the unbound
CTLD of human DNGR-1 has been solved except for a missing
internal segment of 5 residues (Zhang et al., 2012). The structure
reveals that the CTLD of DNGR-1 is similar to that of other CTLDs
in the C-type lectin superfamily. However, none of the latter have
been shown to bind actin, indicating that receptor specificity can
only be understood at themolecular level by solving the structure
of the receptor in complex with its ligand. Here, we used electron
cryomicroscopy and helical image analysis to determine the
structure of DNGR-1 bound to F-actin at 7.7 A˚ resolution. The
DNGR-1 CTLD binds to the interface between two actin protofi-
laments, an unusual topology among actin-binding proteins that
explains the specificity of the receptor for the polymeric ligand.
We have further shown that DNGR-1 affinity for F-actin ismodest
but is compensated by avidity to increase binding strength by
at least three orders of magnitude, thus allowing efficient ligand
recognition. Additionally, using mutants impaired in ligandImmunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc. 839
Figure 1. Structure of F-actin Decorated
with DNGR-1
(A and B) CryoEM images of DNGR-1-decorated
F-actin in a frozen-hydrated state at two different
magnifications, scale bars correspond to 50 nm
and 20 nm, respectively.
(C) Solid surface representation of the 3D density
map of DNGR-1 decorated F-actin at 7.7 A˚ reso-
lution obtained by helical image reconstruction.
F-actin is colored gray and DNGR-1 blue.
(D) Schematic representation of the data in (C):
DNGR-1 binds to the interface between actin
protofilaments making contact with three actin
filament subunits (arbitrarily numbered 1–3).
(E) Fourier shell correlation was performed to
determine the resolution of the 3D map. See also
Figure S1 and Table S1.binding, we have formally demonstrated that F-actin recognition
underlies the ability of DNGR-1 to mediate cross-presentation
of dead-cell-associated antigens. Our data reveal how immune
recognition of cell death can proceed through evolution of a
CTLD optimized to detect exposed cytoskeletal components.
RESULTS
DNGR-1 Binds to the Interface between Actin
Protofilaments
To understand the molecular basis for recognition of F-actin by
DNGR-1, we set out to solve the structure of the DNGR-1 bound
to actin filaments. We expressed the entire ECD of mouse
DNGR-1 (long isoform; Figure S1) as a soluble disulphide-
bonded dimeric protein in 293F cells (Ahrens et al., 2012). The
purified ECD was then used to decorate F-actin in vitro and the
complexes subjected to electron cryomicroscopy (cryoEM)
and helical image analysis (Figures 1A–1D). The resolution
of the reconstructed three-dimensional (3D) density map was
7.7 A˚ as determined by the Fourier shell correlation (FSC)
method at FSC = 0.143 (Figures 1E and S2). The data and anal-
ysis parameters are given in Table S1. The density map shows
that the CTLD of DNGR-1 binds to actin filament subunits with
1:1 stoichiometry (Figures 1C and 2A). We could not observe
densities corresponding to the neck of the bound monomer or
to the other half of the dimer (Figures 1C and 2A), indicating flex-
ibility in the neck region. Each CTLD interacts with three actin
subunits that are helically arranged in F-actin, bridging over
two protofilaments, as well as two neighboring actin subunits
along one protofilament (Figures 1C and 1D and 2A). Thus, the
structure of the complex clearly explains the specificity of the
receptor for polymerized actin.
A Flexible Loop Absent in the DNGR-1 Crystal Structure
Can Be Visualized by cryoEM
The cryoEM density map was used to fit the crystal structure of
the human DNGR-1 CTLD (PDB, 3VPP) (Zhang et al., 2012) onto
F-actin (PDB, 3MFP) (Fujii et al., 2010) (Figure 2A). To build a reli-
able atomicmodel, we used FlexEM (Topf et al., 2008), which uti-
lizes simulated annealing molecular dynamics with restrained
stereochemical and non-bonded interaction terms. We found840 Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc.an unfilled density connected to the CTLD and identified it as
the five residue internal loop (R226–A230 in mouse DNGR-1)
that is missing from the published structure of human DNGR-1
(Figure 2B). This loop is therefore presumably disordered in the
unbound receptor but becomes ordered upon binding to F-actin.
We included the loop based on the cryoEM density map to com-
plete themodel of the DNGR-1 CTLD bound to F-actin (Figure 2A
and Movie S1).
DNGR-1 Employs Three Discrete Surfaces to Interact
with F-actin
The CTLD of DNGR-1 employs three discrete surface regions to
interact with three distinct actin subdomains, each belonging to
a different actin filament subunit (Figures 1D, 2A, 3 andMovie S1;
actin subunits in Figure 3 are numbered and colored as in
Figure 2A). Although the resolution of the cryoEM density map
was insufficient to discriminate individual side chains, the main
chain positions were determined reliably enough to allow identi-
fication of key DNGR-1 residues putatively involved in interaction
with ligand. The most extensive interactions occur with actin
subunit 2 (Figure 2A, right panel, and Figures 3C and 3D) and,
to a lesser extent, with subunit 1 (Figure 2A, left panel, and Fig-
ures 3A and 3B), while a weak contact is made with actin subunit
3 (Figure 2A, left panel). In all, 16 putative interacting residues
were identified, of which 13 are conserved between mouse
and human DNGR-1 (Table S2). Notably, they include mouse
DNGR-1 residuesW141 and E153, which are shown in Figure 3B
at the binding interface with actin subunit 1, and W155 and
W250, which are shown in Figure 3D to interact with actin subunit
2. W155 and W250 of mouse DNGR-1 correspond to W131 and
W227 in human DNGR-1, which were previously proposed to be
important for ligand binding (Zhang et al., 2012).
DNGR-1 Residues Involved in the Interaction with
F-actin
To assess the extent to which the identified residues contribute
to the interaction of DNGR-1 ECDwith F-actin, wemutated them
either singly or in selected combinations. All mutant proteins
could be expressed in 293F cells, and were secreted and accu-
mulated in cell culture supernatants, albeit to varying amounts
(Figure S3). We used immunoblot analysis to measure ECD
Figure 2. Helical Reconstruction Reveals
the Mode of Binding of DNGR-1 to F-actin
and a Flexible LoopMissing from theCrystal
Structure of the DNGR-1 CTLD
(A) Three different views of main chain ribbon
models of F-actin (actin subunits 1, 2, 3 from Fig-
ure 1D colored in orange, magenta, and cyan,
respectively) and DNGR-1 CTLD (rainbow color)
fitted into the density map.
(B) Overlay of the crystal structure of DNGR-1
CTLD (PDB 3VPP; blue) and model (in magenta) of
DNGR-1 CTLD including the flexible loop (R226–
A230; indicated by arrow) fitted into the observed
electron density. See also Figure S2 andMovie S1.concentrations in supernatants and normalized them before as-
sessing binding to in vitro polymerized actin using a dot blot
assay (Ahrens et al., 2012) quantified by densitometric analysis
(Figure 4A). In agreement with data for human DNGR-1 (Zhang
et al., 2012), a W155A W250A double mutant mDNGR-1 ECD
showed no binding to F-actin (Figure 4A). The loss in binding
could largely be recapitulated by mutating W250 alone (likely in-
teracting with A365, G366, and P367 of actin–residue numbering
is for human actin; Figure 3). Single mutation of W155 (likely in-
teracting with A114, E117, and P367 of actin; Figure 3) resulted
in a pronounced decrease in binding (Figure 4A). Mutation of
K251 (likely interacting with Q121 of actin; Figure 3) also had a
profound effect (Figure 4A). All of these residues are predicted
to be involved in the interaction between DNGR-1 and actin sub-
unit 2 (Figure 3 and Table S2). Mutation of additional residues
predicted to be involved in the same interaction surface showed
only a limited effect (e.g., K238A, likely interacting with D80
of actin; Figure 3) or did not impact binding (K195, D248; Fig-
ure 4A). Point mutations (E225A, R226A, Q227A, R228A,
S229A, or Q232A) in the flexible loop missing from the crystal
structure of human DNGR-1 CTLD (see above) did not affect
DNGR-1 binding (Figure 4B). Similarly, replacing the entire loop
by a string of alanine residues (DLoop) dramatically decreased
expression efficiency of the protein (Figure S3), but not its ability
to bind F-actin (Figure 4B). Taken together, these data indicate a
dominant role for W155, W250, and K251 in mediating DNGR-1
contact with actin subunit 2 and suggest that the flexible loop
does not impact the strength of binding.
Among the residues potentially involved in the interaction with
actin subunit 1, W141A and E153A single mutants expressed
poorly (Figure S3) but, compared to other poorly expressed mu-
tants, showed no or very weak binding, respectively (Figure 4A).
In contrast, mutation of N140A and Y150A, alone or in combina-Immunity 42, 839–tion, had only minimal impact on binding
(possibly to the carbonyl groups of actin
S233 and S234; Figure 3). There was no
decrease in binding for H139A, K167A,
and E168A mutants (Figure 4A). Collec-
tively, these data suggest that W141 and
E153 (likely interacting with R196 or form-
ing a carboxyl pair with E237 via Ca2+;
Figure 3) provide the major contribution
to the DNGR-1 interaction with actin sub-unit 1. Although W141 is pointing toward the inside of the CTLD
in the crystal structure of human DNGR-1, it is not part of the
hydrophobic core of the domain and is located instead on the hy-
drophilic side of the three-stranded b sheet formed by the N- and
C-terminal chains. The W141A mutant could be recognized by
two different anti-DNGR-1 antibodies (clones 7H11 and 1F6;
data not shown), suggesting that the protein is not grossly mis-
folded, even if it expresses poorly. We therefore hypothesize
that W141 might flip out upon binding of DNGR-1 to ligand to
interact with a hydrophobic patch on actin (Figure 3). This notion
is supported by the observed electron density, which strongly
suggests that the N-terminal b-hairpin (W141-Y150) could be
unfolded to place W141 en face with actin (Figure 2A and data
not shown). Finally, of the residues putatively involved in the
interaction with actin subunit 3, mutation of K189 and K191,
either singly or doubly, did not have any appreciable impact on
binding of DNGR-1 (Figure 4A).
To confirm that the observed binding pattern of DNGR-1 ECD
mutants to in vitro polymerized F-actin is representative of bind-
ing to actin in dead cells, we utilized a flow cytometry-based
approach in which secondarily-necrotic HeLa cells were stained
with the same proteins used in dot blot analysis (Figure 4C, upper
panel). Using this assay, we saw a pattern of binding identical to
the one observed using dot blot and in vitro polymerized F-actin
(Figure 4C, lower panel, compare with Figure 4A, lower panel).
These data indicate that DNGR-1 binding to F-actin from dead
cells does not differ substantially from that to purified F-actin,
suggesting that, at least under these experimental conditions,
cell death does not markedly alter the structure of the polymer.
Subtle differences between mouse and human DNGR-1
CTLDs could potentially impact binding to F-actin. For example,
among residues predicted to interact with actin subunit 3,
glycine 188 (G188) in mouse replaces arginine (R165) in human849, May 19, 2015 ª2015 Elsevier Inc. 841
Figure 3. The Binding Interface of DNGR-1
CTLD and F-actin
(A and B) N-terminal region of the CTLD interacting
with actin 1 (orange) and actin 3 (cyan).
(C and D) the opposite face of the CTLD inter-
acting with actin 2 (magenta). (A) and (C) are
guides to show the portions displayed in more
detail in (B) and (D), respectively. The viewing
directions of (A)–(D) correspond to the left and
right panels of Figure 2A, respectively, and actin
subunit numbering and coloring is as in Figure 1D.
DNGR-1 CTLD is colored rainbow. Side chains of
the CTLD amino acids identified by mutagenesis
as important for F-actin binding are labeled in
black lettering and are displayed as a stick model
with oxygen in blue, nitrogen in red, and carbon in
gray. Actin side chains that are identified in the
structural model as possible binding partners are
also displayed in the same way and are labeled
in the color of the corresponding actin subunit.
The sequence number and identity of each amino
acid are for mouse CTLD and human platelet
actin. Scale bar corresponds to 10A˚. See also
Table S2.DNGR-1. Changing G188 to arginine (G188R) appeared to in-
crease binding of DNGR-1 to F-actin in the dot blot assay (Fig-
ure 4A) but reduce it the flow cytometry assay (Figure 4C). The
differences might have been an artifact due to the fact that the
mutation adversely impacted expression of the protein (Fig-
ure S3), which resulted in its concentration being limiting in
the flow cytometry, but not dot blot assay. We observed a similar
phenomenon for the DLoop mutant (data not shown), which also
expressed very poorly. Substituting the other non-conserved
residues in mouse DNGR-1 CTLD with their human counterparts
(H139N and K195D) resulted in no detectable change in binding
to F-actin (data not shown).
Taken together, our data suggest that W141 and E153 and, to
a lesser extent N140 and Y150, play a role in the interaction of
mouse DNGR-1 with actin subunit 1 while W155, W250, K251,
and to a lesser extent K238 play a role in the interaction with actin
subunit 2, which is dominant. The limited interaction with subunit
3 as well as the flexible loop appear largely dispensable for
binding.
Mutation of Receptor Residues at the Ligand Interface
Decreases DNGR-1 Affinity for F-actin
Of the ECD mutants described above, we selected for detailed
analysis ones that vary in the strength of F-actin binding such
as K251A, W155A W250A, and N140A Y150A; we excluded
W141A and E153A because of their low expression (Figure S3).
First, we utilized an assay in which decreasing amounts of
wild-type (WT) or mutant DNGR-1 ECD proteins were incubated
with a constant amount of F-actin before filaments were pelleted
by ultracentrifugation (Ahrens et al., 2012). In case of theWT pro-
tein and the N140A Y150Amutant, we observed accumulation of842 Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc.DNGR-1 in the F-actin pellet and deple-
tion from the supernatant. In contrast,
W155A W250A and K251A mutants
largely remained in the supernatant afterpelleting, confirming that neither mutant binds efficiently to
F-actin (Figure 4D).
Tomonitor binding in real-time, we developed amethod based
on biolayer interferometry (BLI) (Abdiche et al., 2008). We mixed
biotinylated and non-biotinylated G-actin (1:4) and allowed it to
polymerize directly on a streptavidin-coated biosensor. Actin
polymerized in this way was stable over prolonged periods of
time (Figure S4A). To confirm the applicability of the technique,
we first tested binding of a-actinin, a well-characterized F-actin
binding protein (Figure S4B). Real-time binding of a-actinin
to the F-actin-coated sensor in a concentration-dependent
fashion was observed (Figure S4B) and steady-state analysis
(Figure S4C) revealed a Kd = 0.15 ± 0.04 mM, in good agreement
with previously published data (Wachsstock et al., 1993). When
WT mDNGR-1 ECD was tested using the same setup, binding
curves displayed fast association kinetics (1.5 3 106 ± 4.2 3
105 M1s1), as well as a fast dissociation phase (8.48 3
101 ± 9.6 3 102 s1) (Figure 5A), with steady state analysis
revealing a Kd = 1.6 ± 0.3 mM (Figure 5B), within the range previ-
ously estimated by pelleting assay (Ahrens et al., 2012). There
was no statistically significant decrease in affinity for mutants
that showed little difference in the dot blot assay, such as
Y150A (data not shown). In contrast, consistent with the dot
blot assay, no binding ofW155AW250A to F-actin was observed
by BLI, indicating a Kd greater than 100 mM (Figures 5C and 5D).
For the K251A mutant, only very weak binding was observed at
the highest concentration used, indicating a Kd > 50 mM (Figures
5E and 5F). Finally, the N140A Y150Amutant showed only amar-
ginal decrease in affinity when compared to the wild-type protein
(Kd = 2.7 ± 1.1 mM; Figures 5G and 5H). Thus, analysis by BLI,
pelleting assay, flow cytometry-based assay and dot blot are
Figure 4. Identification of DNGR-1Residues
Essential for binding F-actin
(A and B) The indicated amounts of F-actin were
spotted onto a nitrocellulose membrane and pro-
bed with WT or mutant DNGR-1 ECD proteins at
equal concentrations. Strength of signal was
quantified and plotted relative to WT (lower panel).
The dot blot data depicted are from one repre-
sentative experiment of three. The quantitation is
based on three experiments, and the data repre-
sent mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001; one-way ANOVA with Dunnett’s
multiple comparisons test.
(C) HeLa cells were UV-irradiated, cultured over-
night to allow secondary necrosis, and stained
with WT or mutant DNGR-1 ECD proteins at equal
concentrations. Binding was analyzed by flow
cytometry using DAPI to identify dead cells (upper
panel) and binding index was calculated (lower
panel). The plots shown are from one representa-
tive experiment of three. The binding index is from
three pooled experiments, and the data represent
mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001; one-way ANOVA with Dunnett’s
multiple comparisons test.
(D) F-actin was incubated with a 2-fold dilution of
WT or mutant DNGR-1 ECD proteins (decreasing
protein concentration indicated by the wedge).
The samples were ultracentrifuged and both pellet
and supernatant fractions were tested for pres-
ence of DNGR-1 proteins by SDS-PAGE and
immunoblot. Data are representative of four ex-
periments for the WT and two experiments for
each mutant. The font color used for the mutant
name is meant to represent the actin subunit to
which the residue normally binds, as depicted in
Figure 1D. See also Figure S3.all concordant and place the DNGR-1 ECD proteins in the
following order of decreasing affinity for F-actin: WT = Y150A >
N140A Y150A > K251A > W155A W250A.
Avidity Increases the Strength of DNGR-1 Binding to F-
actin
The BLI analysis of soluble DNGR-1 binding to F-actin does not
take into account the avidity component of the interaction. In the
case of soluble DNGR-1, the receptor is free to diffuse upon
dissociation from an actin filament but, in the context of the
membrane-anchored protein, the polymeric nature of the ligand
means that when onemolecule of DNGR-1 dissociates, the actin
filament remains bound through interactions with adjacent
DNGR-1 receptors. This makes the likelihood of re-association
much higher, effectively decreasing the off-rate. To assess theImmunity 42, 839–contribution of avidity to the interaction
of DNGR-1 with F-actin, we immobilized
DNGR-1 ECD on the BLI biosensor and
tested binding of short actin filaments
capped and stabilized with gelsolin (see
Experimental Procedures). Steady-state
analysis was not feasible under these
conditions because of the narrow range
of F-actin concentrations that could betested: lowering of concentration was limited by the fact that
F-actin depolymerizes at the pointed end below the critical con-
centration of 0.6 mM (Pollard, 1986) while concentrations above
2 mM caused marked artifacts in the BLI signal due to large fila-
ment size (data not shown). To measure apparent affinities, we
therefore used dynamic analysis of the binding curves and on-
and off-rates obtained with 1 mM of actin filaments (Figure 6A).
Similar to the situation where F-actin is immobilized and
DNGR-1 ECD is free, we found that there is a high binding on-
rate (7.6 3 103 ± 1.0 3 103 M1s1). However, and in contrast
to the previous setup, the dissociation phase was very slow
(off-rate 6.4 3 105 ± 7 3 106 s1), which translated into a Kd
of 8.7 ± 1.8 nM. Thus, the avidity component increases the
strength of the DNGR-1: F-actin interaction by as much as three
orders of magnitude (Kd decrease frommicromolar to nanomolar849, May 19, 2015 ª2015 Elsevier Inc. 843
Figure 5. Real-Time Measurement of
DNGR-1 Binding to F-actin
F-actin was polymerized directly on a BLI sensor
and binding of the indicated concentrations of (A),
WT, (C), W155AW250A (E), K251A and (G), N140A
Y150A DNGR-1 ECD was monitored in real time.
Representative examples of binding curves are
shown. Steady-state analysis of binding for (B),
WT, (D), W155AW250A (F), K251A and (H), N140A
Y150A DNGR-1 is shown. Data points are the
mean ± SD of seven replicate experiments for WT,
three replicate experiments for N140A Y150A
mutant, and two replicate experiments for W155A
W250A and K251A mutants. Numbers represent
best-fit curve values ± SE. The font color used for
the mutant name is meant to represent the actin
subunit to which the residue normally binds, as
depicted in Figure 1D. See also Figure S4.range). This is likely to be an underestimate of the true contribu-
tion of avidity as the latter is directly dependent on the size of
actin filaments, which were kept deliberately short in our exper-
imental setup.
Avidity Can Compensate for Decreased in Affinity in
Ligand-Induced DNGR-1 Internalization
To assess the contribution of affinity versus avidity in a biological
setting, we expressed full-length (trans-membrane) mDNGR-1 in
cells as WT protein or bearing W250A, W155A W250A, K251A,
W141A, E153A, or N140A Y150A mutations (Figure S5A) and844 Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc.tested the response to F-actin. When
crosslinked by either F-actin or a specific
antibody, DNGR-1 underwent endocy-
tosis, which could be read out as loss of
cell surface staining (Figures 6B and
S5B). Treatment of cells on ice resulted
in only minimal loss of signal, excluding
the possibility that the effect was due to
masking of the antibody epitope by
bound ligand (Figure S5C and data not
shown). When treated with anti-DNGR-1
antibody, all of the mutants were able to
internalize (Figure S5D), confirming that
they were not misfolded or otherwise
incapable of entering the endocytic
pathway. In contrast, when treated with
F-actin, no internalization was observed
for the mutants that also showed com-
plete loss of affinity in biochemical as-
says, namely W155A W250A, W250A,
and W141A (Figures 6B and 6C). As ex-
pected from our in vitro binding data,
the N140A Y150A mutant was indistin-
guishable from WT receptor in the inter-
nalization assay (Figure 6C). Importantly,
K251A and E153A mutants were able to
internalize in response to F-actin, albeit
to a lesser extent than WT (Figures 6B
and 6C), lending support to the notionthat the avidity component is able to compensate for a consider-
able decrease in receptor affinity.
Loss of DNGR-1 Affinity for F-actin Impairs Cross-
Presentation of Dead-Cell-Associated Antigens
To further assess the impact of affinity versus avidity on DNGR-1
signaling through Syk, we expressed wild-type DNGR-1 or the
W155A W250A, K251A, E153A, or N140A Y150A mutants in
B3Z-Syk reporter cells, in which Syk activation induces transcrip-
tion of an NFAT-driven b-galactosidase reporter. We measured
activation of the reporter in response to stimulation with dead
Figure 6. Avidity Increases the Strength of
DNGR-1: F-actin Binding
(A) WT DNGR-1 ECD was immobilized on a BLI
sensor and binding of short F-actin filaments
was monitored in real time. Data shown are
representative of six replicate experiments.
Numbers are the mean value ± SD of all six
experiments.
(B) Cells expressing full-length WT or mutant
DNGR-1 trans-membrane proteins were treated
with F-actin, anti-DNGR-1 antibody, F-buffer, or
control antibody, incubated at 37C for 60min and
fixed before staining for DNGR-1 and analysis by
flow cytometry. Profiles depict surface expression
of DNGR-1 WT and selected mutants. The image
is representative of six experiments.
(C) Data from six independent experiments carried
out as in (B), were normalized to the antibody
induced internalization and expressed as mean ±
SD internalization relative to WT. *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001; one-way ANOVA
with Dunnett’s multiple comparisons test. In (A)–
(C), the font color used for the mutant name is
meant to represent the actin subunit to which the
residue normally binds, as depicted in Figure 1D.
(D) B3Z-Syk reporter cells expressing WT or
mutant DNGR-1 receptors were incubated with
decreasing numbers of UV-irradiated HeLa cells
(ratio dead:reporter cells is indicated) or with
plate-bound anti-DNGR-1 antibody or medium
alone at 37C overnight. Activation of the NFAT
reporter was read out at the end of the incubation
period. Data are normalized and expressed as
mean ± SD of three independent experiments.
(E–G) RAW264.7 (RAW) cells were infected with
rVACV OVA and not irradiated (RAW-VACV) or
infected and UV-irradiated (RAW-VACV-UV).
They were fed at the indicated ratios to DCs from
WT or Clec9aegfp/egfp mice transduced or not with
retroviruses encoding WT or the indicated mutant
DNGR-1 constructs. OVA-specific CD8+ T cells
(E and F) or VACV-specific CD8+ T cells (G) were
added, and IFN-g production was measured
after 6 hr.
(H) Cross-presentation of UV-treated BM1TOVA
(BM1TOVA-UV) was also assessed using OVA-
specific CD8+ T cells. In (E), dot plots show the
production of IFN-g by CD8+ T cells specific for OVA at the ratio 3:1 infected cells:DCs. In (F)–(H), graphs depict the frequencies of IFN-g+ CD8+ T cells specific for
OVA (F and H) or VACV (G). (E–H) One representative experiment of three performed is shown. See also Figure S5.cells and normalized the data to the response obtained by stim-
ulation with plate-bound anti-DNGR-1 antibody in order to ac-
count for the varying surface expression of different mutants.
As expected, expression of wild-typeDNGR-1 conferred reporter
cell responsiveness to dead cell stimulation (Figure 6D and data
not shown). In contrast, expression of W155AW250Amutant led
to a complete lack of response (Figure 6D). The K251A and
E153A mutants displayed a small decrease in the ability to signal
via Syk in response to dead cells, whereas the N140A Y150A
mutant showed no impairment (Figure 6D). Thus, the ability of
DNGR-1 mutants to internalize and to signal via Syk in response
to dead cells largely mirror each other and indicate that a large
loss of affinity such as in the case of the K251A and E153A
mutants need not lead to loss of response, likely because of
the avidity component of the interaction.Finally, to assess to what extent these observations apply to
DNGR-1-mediated cross-presentation of dead cell-associated
antigens by DCs, we isolated bone marrow from mice in which
DNGR-1 was genetically ablated (Clec9aegfp/egfp), transduced
it with retroviruses encoding full-length WT, W155A W250A, or
K251A mutant DNGR-1 or with a control empty retrovirus, and
differentiated the cells into DCs under the influence of FLT3L.
Separately, we infectedH-2d RAW264.7 cells with a recombinant
vaccinia virus (VACV) encoding OVA, subjected them (RAW-
VACV-UV) or not (RAW-VACV) to UV radiation at 4 hr post-infec-
tion, and left them overnight to undergo secondary necrosis. The
RAW cells were then cultured with transduced Clec9aegfp/egfp
or non-transduced control WT DCs at different ratios, together
with OVA-specific CTL lines or vaccinia virus-specific H-2b-
restricted CD8+ effector T cells purified from mice infected withImmunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc. 845
Figure 7. Distinct DNGR-1 Footprint on F-actin
Schematic depiction of binding footprints for canonical F-actin binding pro-
teins on F-actin compared with the footprint of the DNGR-1 CTLD.VACV WR. Interferon-g (IFN-g) production was assessed 6 hr
later. In this assay, the non-irradiated RAW-VACV cells served
as a source of virus that could infect DCs directly, allowing for
direct antigen presentation to the CD8+ T cells (positive control).
In contrast, the UV-irradiated RAW-VACV-UV cells underwent
secondary necrosis and contained only inactive virus that could
not infect DCs. As such, they served as a source of dead cell-
associated viral antigens (including OVA) for cross-presentation.
When direct presentation was allowed (RAW-VACV), all DCs
were equally competent at stimulating antigen-specific CD8+
T cells, irrespective of DNGR-1 expression (Figures 6E–6G). In
contrast, when restricted to cross-presentation (RAW-VACV-
UV), theClec9aegfp/egfp DCs transducedwith control virus showed
a pronounced defect in stimulating antigen-specific CD8+ T cells
(Figures 6E–6G). This defect could be rescued by reconstitution
withWTDNGR-1 (Figures6E–6G), aspreviously reported (Sancho
et al., 2009). In contrast, reconstitution with W155A W250A
DNGR-1 did not rescue (Figures 6E–6G), consistent with the
inability of that mutant to bind F-actin. The K251A mutation
showed an intermediate phenotype, restoring cross-presentation
of dead cell-associated antigens to a lower extent than theWT re-
ceptor (Figures 6E–6G) and lower thanmight have been expected
from its activity in the internalization and reporter assays (see
above). It is unclear whether this disparity relates to expression
of the receptor or Syk in DCs versus reporter cells, or to a greater
extent of crosslinking being required for signaling for cross-pre-
sentation in DCs versus reporter construct activation in reporter
cells. Similar results were obtained using secondarily necrotic H-
2bm1 fibroblasts expressingOVA (Sancho et al., 2009) as a source
of dead cell-associated antigen for cross-presentation to OVA-
specific CD8+ T cells (Figure 6H). Thus, these data formally prove
that the ability of DNGR-1 to bind F-actin is at the heart of its func-
tion in cross-presentation of dead-cell-associated antigens.
DISCUSSION
DNGR-1, a C-type lectin-like receptor expressed by DCs, is a
sensor of cell damage and the only known transmembrane pro-846 Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc.tein able to bind actin in the extracellular space. Here, we have
solved the structure of DNGR-1 in complex with its ligand,
F-actin, and identified the contact surfaces and residues essen-
tial for the interaction. The CTLD of DNGR-1 binds to three actin
subunits that are helically arranged in F-actin, crosslinking two
actin protofilaments, as well as two neighboring actin subunits
along the protofilament, and making contacts with each actin
subunit. We further defined a flexible loop, which is absent in
the crystal structure and appears to be stabilized by interaction
with F-actin. Notably, we observed no decrease in affinity upon
removal of this loop. This is likely due to the entropy cost of
ordering the loop, which cancels out the enthalpy gain of the
interaction.
The mode of DNGR-1 binding shares some features with that
of coronin (Galkin et al., 2008a; Ge et al., 2014), the Arp2/3 com-
plex (Rouiller et al., 2008) or Salmonella SipA protein (Lilic et al.,
2003) in that they all bind across the two protofilaments. How-
ever, the binding site of DNGR-1 comprises a relatively small
F-actin surface and only partially overlaps with that of any of
the above proteins. It is also distinct from the binding sites of
other intracellular F-actin binding proteins, which generally
bind to the outer surfaces of filaments (dos Remedios et al.,
2003; Galkin et al., 2008b; Galkin et al., 2011; Holmes et al.,
2003; Thompson et al., 2014) (Figure 7). The fact that the
DNGR-1 binding site is distinctive means that it is less likely to
be encumbered by other actin-binding proteins that might deco-
rate actin filaments, which is in line with the role of DNGR-1 as a
general sensor of cell damage. However, the latter function ap-
pears at odds with the rather modest affinity of the DNGR-1
CTLD for F-actin. Notably, we have uncovered a key role for
avidity in the DNGR-1: F-actin interaction that helps explain
why DNGR-1 can bind tightly to its ligand under physiological
conditions. The avidity component has been noted for other lec-
tin receptors recognizing multivalent polysaccharide ligands,
ranging from bacterial toxins (Kitov et al., 2000) to virus capsid
glycoproteins (Connor et al., 1994) and can lead to an affinity
increase of as much as six orders of magnitude (Collins
and Paulson, 2004). DNGR-1 avidity is further favored by the
homo-dimeric nature of the receptor, whereby binding of one
CTLD facilitates binding by the second (data not shown). The
importance of avidity in ligand binding has been noted for
the T and B cell receptors, demonstrating a parallel between
receptors of the innate and adaptive immune systems.
It has been reported that DNGR-1 binds to F-actin that is com-
plexed to the calponin homology-based actin binding domains
of other cytoskeletal molecules (Zhang et al., 2012). Our data
do not support the notion that the DNGR-1 binding site is specific
to complexed F-actin. Nevertheless, it is conceivable that calpo-
nin homology-based actin binding proteins such as a-actinin and
b-spectrin could contribute to the strength of DNGR-1 binding
by crosslinking F-actin and facilitating receptor bridging of two
filaments (Ahrens et al., 2012). Whether neck region flexibility is
sufficient to allow the second CTLD to bind in trans to other actin
filaments remains to be determined. At least under the condi-
tions of our study, it does not appear to be the case, as we did
not observe any sign of F-actin bundling upon incubation with
the DNGR-1 ECD (Figure 1A). This is not to say that actin binding
proteins cannot facilitate or impair DNGR-1 binding indirectly by
altering the conformation of the filaments. Similarly, it is worth
noting that some of the actin residues at, or near the interaction
surfaces that we have mapped, are amenable to post-transla-
tional modifications including ubiquitinylation, phosphorylation,
and nitration (Terman and Kashina, 2013). It is therefore
intriguing to speculate that decoration of F-actin by actin binding
proteins or post-translational modifications of actin taking place
as a result of cellular metabolism or cell death modality could
contribute to obscuring or revealing the DNGR-1 binding site,
thereby modulating immune responses to dead cells.
EXPERIMENTAL PROCEDURES
Mice
Clec9aegfp/egfp mice (Sancho et al., 2009) were backcrossed more than ten
times to C57BL/6J-Crl and bred at CNIC in specific pathogen-free conditions.
All animal experiments were performed in accordance with national and insti-
tutional guidelines for animal care and were approved by the CNIC Ethical
Committee for Animal Welfare and by the Spanish Ministry for Rural and
Marine Environment.
DNGR-1 ECD Proteins
DNA coding for WT or mutant mouse DNGR-1 extracellular domain (ECD;
K57–I264) was cloned into p3xFLAG-CMV-9 expression vector (Sigma-
Aldrich) and all the constructs were verified by sequencing. The proteins
were expressed by transient transfection in 293F cells as described previously
(Ahrens et al., 2012). All proteins were tagged with 3xFLAG tag at their N ter-
minus and purified using a combination of affinity chromatography on M2
anti-FLAG gel matrix (Sigma-Aldrich) with 3xFLAG peptide elution and size-
exclusion chromatography on Superdex S200 column (GE-Healthcare).
Actin and Actin-Binding Proteins
Human platelet actin, biotinylated rabbit muscle actin, rabbit skeletal muscle
a-actinin, and human recombinant plasma gelsolin were purchased from
Cytoskeleton. Before each experiment, lyophilized actin was reconstituted in
G-buffer (5 mM Tris-HCl, pH 8.0 + 0.2 mM CaCl2). Polymerization was carried
out in F-buffer (10mMTris-HCl,pH7.5+50mMKCl +2mMMgCl2+1mMATP).
Cryo-Electron Microscopy And Analysis
Human platelet actin was polymerized in a 30 ml solution of 25 mM HEPES
buffer (pH 7.5), 100 mM KCl, 1 mM MgCl2, and 1 mM ATP. F-actin and
DNGR-1weremixed in final concentrations of 1.8 mMand 7.6 mM, respectively.
A 2.4 ml aliquot was applied onto a holey carbon molybdenum EM grid (R0.6/
1.0, Quantifoil), blotted and plunge-frozen into liquid ethane by Vitrobot (FEI).
The grid was observed at temperatures of 80 K using a JEOL JEM3200FSC
electron cryomicroscope equipped with an U-type energy filter and a field-
emission electron gun operated at 200 kV. Zero energy-loss images, with a
slit setting to remove electrons of an energy-loss larger than 10 eV, were re-
corded on a 4k 3 4k 15 mm/pixel slow-scan CCD camera (TemCam-
F415MP, TVIPS) at a magnification of 109,489 3 (1.37 A˚/pixel), a defocus
range of 1.0–2.0 mm and an electron dose of 20 electrons/A˚2. Helical image
analysis and 3D image reconstruction was carried out as previously described
(Fujii et al., 2010) by using the iterative helical real-space refine method (Egel-
man, 2000). The resolution of the reconstructed 3D image was determined by
the Fourier shell correlation (FSC) method, in which the filament images were
randomly divided into two sets, image analysis was carried out independently
for the two sets of data to produce two 3D images, and the FSCwas calculated
from these two 3D images.
DNGR-1 Mutagenesis
Mutants were prepared using QuikChange II XL kit (Agilent Technologies) or
QuikChange Lightning kit (Agilent Technologies) with the following primers:
50-GACTGCAGCCCTTGTCCAGCCAACTGGATTCAGAATGG-30 for H139A,
50-GCAGCCCTTGTCCACACGCCTGGATTCAGAATGGAAAAAG-30 for N140A,
50-GCAGCCCTTGTCCACACAACGCCATTCAGAATGGAAAAAGTTG-30 for
W141A, 50-GATTCAGAATGGAAAAAGTTGTTACGCCGTCTTTGAACGCTGG
GAAATGTGG-30 for Y150A, 50-GGAAAAAGTTGTTACTATGTCTTTGCCCGCTGGGAAATGTGGAACATCAG-30 for E153A, 50-GTTGTTACTATGTCTTTGAA
CGCGCCGAAATGTGGAACATCAGTAAGAAG-30 for W155A, 50-CATCAGTA
AGAAGAGCTGTTTAGCCGAGGGCGCTAGTCTCTTTC-30 for K167A, 50-CAT
CAGTAAGAAGAGCTGTTTAAAAGCCGGCGCTAGTCTCTTTCAAATAGAC-30
for E168A, 50-GAAGAAATGGAGTTCATCAGCAGTATAAGGAAACTCAAAGGA
GGAAATAAATATTGGG-30 for G188R, 50-GGAGTTCATCAGCAGTATAGGGG
CCCTCAAAGGAGGAAATAAATATTGGG-30 for K189A, 50-CATCAGCAGTATA
GGGAAACTCGCCGGAGGAAATAAATATTGGGTG-30 for K191A, 50-GGAG
TTCATCAGCAGTATAGGGGCCCTCGCCGGAGGAAATAAATATTGGG-30 for
K189A K191A, 50-GGGAAACTCAAAGGAGGAAATGCCTATTGGGTGGGAGT
GTTTC-30 for K195A, 50-GACTTGTTGCCAGCAGCGAGACAGCGATCAGCCG
GCC-30 for E225A, 50-GACTTGTTGCCAGCAGAAGCGCAGCGATCAGCCG
GCC-30 for R226A, 50-GACTTGTTGCCAGCAGAAAGAGCCGCCTCAGCCGG
CCAGATCTGTGG-30 for Q227A R228A, 50-GTTGCCAGCAGAAAGACAGC
GAGCCGCCGGCCAGATCTGTGGATACC-30 for S229A, 50-GCAGAAAGAC
AGCGATCAGCCGGCGCCATCTGTGGATACCTCAAAGATTC-30 for Q232A
50-CTGAGATGAGAGTAGAATCGGCGAGGTATCCACAGATCTGGCC-30 for
K238A, 50-CTCACAGATAAAATATTTCCAGCTGGCGCACTTATCTGAGATGA
GAGTAGAATC-30 for D248A, 50-CATCTCAGATAAGTGCGATAGCGCCAAAT
ATTTTATCTGTGAGAAGAAGGC-30 for W250A, 50-CTCAGATAAGTGCGATA
GCTGGGCCTATTTTATCTGTGAGAAGAAGG-30 for K251, and 50-GAATCTTT
GAGGTATCCACAGATGGCGGCGGCGGCGGCGGCGGCTGCTGGCAACAA
GTCAGAGAG-30 for DLoop. All constructs were verified by sequencing.
Dot Blot
F-actin stabilized with 5 mM phalloidin (Life Technologies) was spotted onto
a nitrocellulose membrane (Whatman) pre-soaked in PBS in 2-fold dilution
series starting at 10 mg/ml. The membrane was blocked in 5% milk in PBS +
0.05% Tween-20 overnight and incubated with supernatants containing
relevant proteins. Binding of DNGR-1 WT or mutants was tested using HRP
conjugated M2 anti-FLAG antibody (Sigma-Aldrich). Signal was revealed
by SuperSignal West Pico Chemiluminescent substrate (Thermo Fisher).
Signal in blots was quantified using ImageJ software and compared to WT.
Each experiment was repeated three times and statistical analysis (one-way
ANOVAwith Dunnett’s multiple comparisons test) was performed in GraphPad
Prism version 6.0 for Mac OS X (GraphPad Software).
Dead Cell Staining
HeLa cells were UV-irradiated (UVC 240mJ/cm2) and left overnight to undergo
secondary necrosis. Following incubation, the cells were recovered, washed in
FACS buffer, and stained with supernatants containing a fixed concentration
of WT or mutant DNGR-1 proteins. Binding of DNGR-1 was revealed by Cy3
anti-FLAG antibody (Sigma-Aldrich) and data were acquired on LSR Fortessa
flow cytometer (BD Biosciences). DAPI was used to discriminate dead cells,
and strength of DNGR-1 staining was compared to cells stained with second-
ary antibody only. Data were analyzed using FlowJo version 9.6.2 software
(Treestar). To compare between mutant and WT proteins, we calculated the
binding index as the mean fluorescence intensity of DNGR-1+ cells multiplied
by their frequency in the DAPI+ population and normalized to WT. Each exper-
iment was repeated 3 times and statistical analysis (one-way ANOVA with
Dunnett’s multiple comparisons test) was performed in GraphPad Prism
version 6.0 for Mac OS X (GraphPad Software).
Pelleting Assay
2 mg of F-actin in 10 ml of F-buffer was mixed with different amounts of purified
WT or mutant DNGR-1 ECD proteins (2-fold dilution series starting at 5 mg)
in 30 ml of PBS. As a control, 5 mg of DNGR-1 ECD was mixed with F-buffer
only. Mixtures were incubated at room temperature for 1 hr and pelleted
at 120,000 3 g for 90 min. Supernatants and pellets were separated by
SDS-PAGE and immunoblotted with HRP-conjugated M2 anti-FLAG antibody
(Sigma-Aldrich). Signal was revealed using the SuperSignal West Pico Chemi-
luminescent substrate (Thermo Fisher).
Biolayer Interferometry
BLI experiments were carried out using Octet RED96 System (ForteBio). For
experiments with DNGR-1 ECD in solution, streptavidin (SA) biosensors
(ForteBio) were pre-wetted in water for 20 min and equilibrated in F-buffer
for 30 s. Biotinylated and non-biotinylated G-actin were mixed in 1:4 ratio,Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc. 847
diluted to final concentration of 1 mM in 200 ml of F-buffer, and allowed to
polymerize directly on the SA biosensors. Free binding sites on SA were
blocked using 10 mg/ml biocytin (Sigma-Aldrich) in F-buffer + 0.1% (w/v)
BSA + 0.02% (v/v) Tween-20 (both Sigma-Aldrich). Baseline was determined
in the interaction buffer (F-buffer + 0.1% (w/v) BSA + 0.02% (v/v) Tween-20)
and association with DNGR-1 WT or mutants at various concentrations
(2.5 mM, 1 mM, 0.4 mM, 0.167 mM and 0.064 mM) was monitored for 300 s.
Dissociation was monitored for 900 s. Data analysis was performed in Data
Analysis 4.1 software (ForteBio). Non-linear regression (curve fit, one site –
specific binding) for the steady-state analysis was performed using GraphPad
Prism version 6.0 for Mac OS X (GraphPad Software). The experiment was
repeated seven times for WT and at least two times for each of the tested
mutant proteins. For experiments with F-actin in solution, 23 mM actin was
polymerized in the presence of 0.23 mM gelsolin (ratio 100:1) to obtain short
F-actin filaments because large filaments caused artifacts in the BLI signal.
Anti-FLAG (FLG) biosensors (ForteBio) were pre-wetted in water for 20 min
and equilibrated in PBS for 60 s. 3xFLAG-tagged DNGR-1 ECD was diluted
to 0.15 mM in PBS and immobilized on the sensor for 180 s. Baseline was
determined in interaction buffer (F-buffer + 0.1% [w/v] BSA + 0.02% [v/v]
Tween-20) containing 5 mM phalloidin. Association of 1 mM short F-actin fila-
ments was monitored for 600 s in phalloidin-free interaction buffer. Dissocia-
tion phase was carried out for 900 s in interaction buffer with 5 mM phalloidin
to prevent depolymerization of F-actin bound to DNGR-1. The experiment
was repeated six times.
Cells
All cells were cultured in RPMI 1640 medium supplemented with glutamine,
penicillin, streptomycin, 2-mercaptoethanol (all from Invitrogen), and 10%
heat-inactivated fetal calf serum (Source BioScience). For Flt3L DC cultures,
medium was additionally supplemented with 150 ng/ml Flt3L (R&D Systems).
For the B3Z-Syk reporter experiments, the cells were switched to AIM-V
medium (Invitrogen).
Internalization Assay
Full-length DNGR-1WT andmutant constructs were cloned into pMSCV retro-
viral vector, verified by sequencing, and used to produce retroviral vectors.
Phoenix cells retrovirally transduced with WT or mutant DNGR-1 constructs
were treated with 1 mM F-actin, F-buffer, 5 mg/ml anti-DNGR-1 (clone 7H11),
or 5 mg/ml isotype control antibody, and incubated at 37C for the indicated
times. The cells were washed in ice-cold 5 mM EDTA, harvested on ice and
fixed in 2% formaldehyde. Fixed cells were washed twice in FACS buffer
(5 mM EDTA, 1% FCS, 0.0125% NaN3) and surface-stained with PE-conju-
gated anti-DNGR-1 antibody (clone 1F6). Staining of membrane DNGR-1
was analyzed using LSR Fortessa flow cytometer (BD Biosciences). Data anal-
ysis was carried out in FlowJo version 9.6.2 software (Treestar). The extent of
internalization was determined by comparing the median fluorescence inten-
sity (MFI) of F-actin treated samples with F-buffer treated samples, and anti-
DNGR-1 treated samples with isotype control treated samples. The data
were normalized to the maximal internalization induced by antibody treatment
by using formula (MFI [F-buffer] – MFI [F-actin]) / (MFI [isotype control] – MFI
[anti-DNGR-1]) and plotted relative to the internalization ofWT. The experiment
was repeated six times and statistical analysis (one-wayANOVAwithDunnett’s
multiple comparisons test) was performed in GraphPad Prism version 6.0 for
Mac OS X (GraphPad Software). To check whether 7H11 binding interfered
with 1F6 binding, we treated the cells with 7H11 and incubated them on ice
to prevent internalization before being fixed and analyzed as described above.
B3Z-Syk Reporter Assay
The DNGR-1 reporter assay was described previously (Sancho et al., 2009).
Briefly, 1 3 105 B3Z-Syk reporter cells transduced with WT or indicated
mutant DNGR-1 proteins were incubated with previously UV-irradiated
(UVC, 480 mJ/cm2) HeLa cells at the indicated ratios, or with plate-bound
anti-DNGR-1 antibody (clone 7H11), or in medium alone for 16–18 hr in a
96-well plate at 37C and 5% CO2. Following incubation, the cells were
washed in PBS and LacZ activity was determined by lysing the cells in
CPRG (Roche)-containing buffer and measuring O.D. 595 (using O.D. 655 as
a reference) at multiple time points. Each experiment was repeated three times
with all treatments in duplicate. Themean response to plate-bound antibody in848 Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc.each experiment was taken as a reference to which responses to other treat-
ments were normalized. Normalized data were plotted as mean ± SD using
GraphPad Prism version 6.0 for Mac OS X (GraphPad Software).
Antigen-Presentation Assays
Mouse Flt3L DCswere generated by culturing BMcells in complete RPMI 1640
medium (with 5mMglutamine, penicillin, streptomycin, 2-mercaptoethanol [all
from Invitrogen], and 10% heat-inactivated fetal bovine serum [Sigma]) in the
presence of 150 ng/ml Flt3L (R&D) as previously described (Iborra et al., 2012).
For generation of retrovirally transduced Flt3L DCs, bone marrow cells from
DNGR-1-deficient mice were seeded in 6-well plates (2 3 106 cells per well)
and spin-infected with supernatants containing pMSCV-based retroviral vec-
tors encoding GFP and WT or mutant DNGR-1 on days 0, 1, and 2. Flt3L
150 ng/ml (R&D) was added to cultures on day 0 and 3. GFP and DNGR-1
expression was assessed at day 8 and routinely indicated a 50% transduction
efficiency. On day 9, most cells had a typical DC morphology and a CD8a-like
phenotype (MHC class II+, CD11c+, CD24hi, CD11blo, B220) and were har-
vested and used for antigen presentation studies. Sources of antigen were
RAW264.7 cells (cultured in DMEM-based complete medium) infected with
rVACV OVA (kind gift from JonathanW. Yewdell and Jack R. Bennink, National
Institutes of Health) for 4 hr and then treated with UVC (250 mJ/cm2) to inacti-
vate the virus (RAW-VACV-UV) or left non-irradiated (RAW-VACV) and further
cultured for 16 hr before use, as described (Iborra et al., 2012). Alternatively,
H-2bm1 fibroblasts expressing OVA (Sancho et al., 2009) irradiated and
cultured as above were used. Responder T cells were either CD8+ T cells pu-
rified from spleens of mice infected intradermally 7 days before with rVACV
OVA or CD8+ T cell lines specific for OVA. DCs, antigen sources, and
responder T cells were co-cultured for 6 hr in complete medium additionally
supplemented with non-essential amino acids, HEPES, and sodium-pyruvate
(Invitrogen). Brefeldin A (Sigma, 5 mg/ml) was added for the last 4 hr of culture
and cells were then stained with PE-anti-CD8a, fixed with 4% PFA and incu-
bated with APC-anti-IFN-g during permeabilization with 0.1% saponin. An
average of 5,000 T cells was analyzed in each sample to assess percent
positive for IFN-g.
ACCESSION NUMBERS
The accession numbers for the data reported in this paper are Electron
Microscopy Data Bank, EMD-6102; Protein Data Bank, RCSB: rcsb160368;
and PDB, 3J82.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, Supplemental
Experimental Procedures, and one movie and can be found with this article
online at http://dx.doi.org/10.1016/j.immuni.2015.04.009.
AUTHOR CONTRIBUTIONS
P.H. produced all DNGR-1 proteins, analyzed their binding to F-actin, and
carried out the internalization and reporter assays. T.F. and K.N. generated
and analyzed electron cryomicroscopy data with assistance from Y.Y. and
performed protein docking. S.I. and D.S. carried out all antigen-presentation
experiments. J.H., O.S., S.A., S.K., M.W., and D.S. provided advice and
contributed to design of experiments. P.H. and C.R.S. designed the study,
analyzed data, and wrote the manuscript with assistance from K.N. and D.S.
ACKNOWLEDGMENTS
We thank all members of the Immunobiology Laboratory for helpful discus-
sions and suggestions. We thank the Flow Cytometry, Equipment Park, and
Structural Biology Science Technology Platforms for assistance. This work
was funded by Cancer Research UK, a prize from Fondation Bettencourt-
Schueller, and a grant from the European Research Council (ERC Advanced
Researcher Grant AdG- 2010-268670) to C.R.S., and by JSPS KAKENHI Grant
number 25000013 to K.N. and 25711010 to T.F. Work in the D.S. laboratory is
funded by the CNIC and grants from the Spanish Ministry of Economy and
Competitiveness (SAF-2013-42920R) and the European Research Council
(ERC Starting Independent Researcher Grant StG-2010-260414).
Received: August 7, 2014
Revised: January 13, 2015
Accepted: April 24, 2015
Published: May 12, 2015
REFERENCES
Abdiche, Y., Malashock, D., Pinkerton, A., and Pons, J. (2008). Determining ki-
netics and affinities of protein interactions using a parallel real-time label-free
biosensor, the Octet. Anal. Biochem. 377, 209–217.
Ahrens, S., Zelenay, S., Sancho, D., Hanc, P., Kjær, S., Feest, C., Fletcher, G.,
Durkin, C., Postigo, A., Skehel, M., et al. (2012). F-actin is an evolutionarily
conserved damage-associated molecular pattern recognized by DNGR-1, a
receptor for dead cells. Immunity 36, 635–645.
Caminschi, I., Proietto, A.I., Ahmet, F., Kitsoulis, S., Shin Teh, J., Lo, J.C.,
Rizzitelli, A., Wu, L., Vremec, D., van Dommelen, S.L., et al. (2008). The den-
dritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine
enhancement. Blood 112, 3264–3273.
Collins, B.E., and Paulson, J.C. (2004). Cell surface biology mediated by
low affinity multivalent protein-glycan interactions. Curr. Opin. Chem. Biol. 8,
617–625.
Connor, R.J., Kawaoka, Y., Webster, R.G., and Paulson, J.C. (1994). Receptor
specificity in human, avian, and equine H2 and H3 influenza virus isolates.
Virology 205, 17–23.
dos Remedios, C.G., Chhabra, D., Kekic, M., Dedova, I.V., Tsubakihara, M.,
Berry, D.A., and Nosworthy, N.J. (2003). Actin binding proteins: regulation of
cytoskeletal microfilaments. Physiol. Rev. 83, 433–473.
Egelman, E.H. (2000). A robust algorithm for the reconstruction of helical fila-
ments using single-particle methods. Ultramicroscopy 85, 225–234.
Fujii, T., Iwane, A.H., Yanagida, T., and Namba, K. (2010). Direct visualization
of secondary structures of F-actin by electron cryomicroscopy. Nature 467,
724–728.
Galkin, V.E., Orlova, A., Brieher, W., Kueh, H.Y., Mitchison, T.J., and Egelman,
E.H. (2008a). Coronin-1A stabilizes F-actin by bridging adjacent actin proto-
mers and stapling opposite strands of the actin filament. J. Mol. Biol. 376,
607–613.
Galkin, V.E., Orlova, A., Cherepanova, O., Lebart, M.C., and Egelman, E.H.
(2008b). High-resolution cryo-EM structure of the F-actin-fimbrin/plastin
ABD2 complex. Proc. Natl. Acad. Sci. USA 105, 1494–1498.
Galkin, V.E., Orlova, A., Kudryashov, D.S., Solodukhin, A., Reisler, E.,
Schro¨der, G.F., and Egelman, E.H. (2011). Remodeling of actin filaments by
ADF/cofilin proteins. Proc. Natl. Acad. Sci. USA 108, 20568–20572.
Ge, P., Durer, Z.A., Kudryashov, D., Zhou, Z.H., and Reisler, E. (2014). Cryo-
EM reveals different coronin binding modes for ADP- and ADP-BeFx actin fil-
aments. Nat. Struct. Mol. Biol. 21, 1075–1081.
Holmes, K.C., Angert, I., Kull, F.J., Jahn, W., and Schro¨der, R.R. (2003).
Electron cryo-microscopy shows how strong binding of myosin to actin
releases nucleotide. Nature 425, 423–427.
Huysamen, C., Willment, J.A., Dennehy, K.M., and Brown, G.D. (2008).
CLEC9A is a novel activation C-type lectin-like receptor expressed on
BDCA3+ dendritic cells and a subset of monocytes. J. Biol. Chem. 283,
16693–16701.Iborra, S., Izquierdo, H.M., Martı´nez-Lo´pez, M., Blanco-Mene´ndez, N., Reis e
Sousa, C., and Sancho, D. (2012). The DC receptor DNGR-1 mediates cross-
priming of CTLs during vaccinia virus infection in mice. J. Clin. Invest. 122,
1628–1643.
Kitov, P.I., Sadowska, J.M., Mulvey, G., Armstrong, G.D., Ling, H., Pannu,
N.S., Read, R.J., and Bundle, D.R. (2000). Shiga-like toxins are neutralized
by tailored multivalent carbohydrate ligands. Nature 403, 669–672.
Lilic, M., Galkin, V.E., Orlova, A., VanLoock, M.S., Egelman, E.H., and
Stebbins, C.E. (2003). Salmonella SipA polymerizes actin by stapling filaments
with nonglobular protein arms. Science 301, 1918–1921.
Pollard, T.D. (1986). Rate constants for the reactions of ATP- and ADP-actin
with the ends of actin filaments. J. Cell Biol. 103, 2747–2754.
Poulin, L.F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J.L.,
Keller, A.M., Joffre, O., Zelenay, S., Nye, E., et al. (2010). Characterization
of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse
CD8alpha+ dendritic cells. J. Exp. Med. 207, 1261–1271.
Poulin, L.F., Reyal, Y., Uronen-Hansson, H., Schraml, B.U., Sancho, D.,
Murphy, K.M., Ha˚kansson, U.K., Moita, L.F., Agace, W.W., Bonnet, D., and
Reis e Sousa, C. (2012). DNGR-1 is a specific and universal marker of mouse
and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid
tissues. Blood 119, 6052–6062.
Rouiller, I., Xu, X.P., Amann, K.J., Egile, C., Nickell, S., Nicastro, D., Li, R.,
Pollard, T.D., Volkmann, N., and Hanein, D. (2008). The structural basis of actin
filament branching by the Arp2/3 complex. J. Cell Biol. 180, 887–895.
Sancho, D., Moura˜o-Sa´, D., Joffre, O.P., Schulz, O., Rogers, N.C., Pennington,
D.J., Carlyle, J.R., and Reis e Sousa, C. (2008). Tumor therapy in mice via
antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 118,
2098–2110.
Sancho, D., Joffre, O.P., Keller, A.M., Rogers, N.C., Martı´nez, D., Hernanz-
Falco´n, P., Rosewell, I., and Reis e Sousa, C. (2009). Identification of a den-
dritic cell receptor that couples sensing of necrosis to immunity. Nature 458,
899–903.
Terman, J.R., and Kashina, A. (2013). Post-translationalmodification and regu-
lation of actin. Curr. Opin. Cell Biol. 25, 30–38.
Thompson, P.M., Tolbert, C.E., Shen, K., Kota, P., Palmer, S.M., Plevock,
K.M., Orlova, A., Galkin, V.E., Burridge, K., Egelman, E.H., et al. (2014).
Identification of an actin binding surface on vinculin that mediates mechanical
cell and focal adhesion properties. Structure 22, 697–706.
Topf, M., Lasker, K., Webb, B., Wolfson, H., Chiu, W., and Sali, A. (2008).
Protein structure fitting and refinement guided by cryo-EM density. Structure
16, 295–307.
Wachsstock, D.H., Schwartz, W.H., and Pollard, T.D. (1993). Affinity of alpha-
actinin for actin determines the structure and mechanical properties of actin
filament gels. Biophys. J. 65, 205–214.
Zelenay, S., and Reis e Sousa, C. (2013). Adaptive immunity after cell death.
Trends Immunol. 34, 329–335.
Zelenay, S., Keller, A.M., Whitney, P.G., Schraml, B.U., Deddouche, S.,
Rogers, N.C., Schulz, O., Sancho, D., and Reis e Sousa, C. (2012). The den-
dritic cell receptor DNGR-1 controls endocytic handling of necrotic cell anti-
gens to favor cross-priming of CTLs in virus-infected mice. J. Clin. Invest.
122, 1615–1627.
Zhang, J.G., Czabotar, P.E., Policheni, A.N., Caminschi, I., Wan, S.S.,
Kitsoulis, S., Tullett, K.M., Robin, A.Y., Brammananth, R., van Delft, M.F.,
et al. (2012). The dendritic cell receptor Clec9A binds damaged cells via
exposed actin filaments. Immunity 36, 646–657.Immunity 42, 839–849, May 19, 2015 ª2015 Elsevier Inc. 849
